Markets

Celladon Corp. (CLDN) Jumps: Stock Adds 11.3% in Session - Tale of the Tape

Celladon Corporation ( CLDN ) was a big mover last session, as its shares rose over 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the trend for the company since Aug 12, as the stock is now up above 21%.

In the last 30 days, the company witnessed one positive estimate revision and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday's jump can turn into more strength down the road.

Celladon Corp. currently has a Zacks Rank #2 (Buy) while its Earnings ESP is positive.

Other better-ranked stocks in the biomedical/gene industry include Gilead Sciences Inc. ( GILD ), Cambrex Corporation. ( CBM ) and China Biologic Products, Inc. ( CBPO ). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

CELLADON CORP (CLDN): Free Stock Analysis Report

CAMBREX CORP (CBM): Free Stock Analysis Report

CHINA BIOLOGIC (CBPO): Get Free Report

GILEAD SCIENCES (GILD): Free Stock Analysis Report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

GILD CBPO

Other Topics

Investing Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More